Education
About Us
Working with TipRanks
Follow Us
Cibus (CBUS)
NASDAQ:CBUS
CBUS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.75 - $21.24
Previous CloseN/A
Volume64.89K
Average Volume (3M)177.14K
Market Cap
$63.25M
Enterprise Value$304.64M
Total Cash (Recent Filing)$3.01M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.95
Next Earnings
May 08, 2025EPS Estimate
-0.51Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-10.72
Shares Outstanding32,850,025
10 Day Avg. Volume148,325
30 Day Avg. Volume177,139
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)14.60
Price to Cash Flow (P/CF)-1.10
P/FCF Ratio0.00
Enterprise Value/Market Cap4.82
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit71.48
Enterprise Value/Ebitda-1.26
Forecast
1Y Price Target
$21.50Price Target Upside1227.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Cibus News
PremiumCompany Announcements
Cibus, Inc. Earnings Call: Strategic Progress Amid Challenges
PremiumCompany Announcements
Cibus, Inc. Reports Progress in Gene Editing and Financial Results
PremiumPre-Earnings
Is CBUS a Buy, Before Earnings?---
Bulls Say, Bears Say
Bulls Say
EU Regulatory SupportThe EU Council's support for advancing negotiations on gene-editing techniques is favorable, paving the way for potential use in European agriculture and global adoption.
Market ExpansionCibus is increasing its customers for weed management in Rice, with a total of four customers representing 40% of the addressable market in North and Latin America.
Revenue GrowthCibus' revenues increased by 135% year-over-year, mainly through collaboration agreements and sales related to developing a palm oil alternative.
Bears Say
Dilution ConcernsFollowing the announcement of the equity raise, the model was adjusted to reflect the dilution effect of the revised share count.
Leadership ChangeCibus' CEO, Rory Riggs, will be stepping down from his leadership position, marking a significant leadership change.
Operational GoalsCibus did not meet its stated goal of achieving an operational soybean platform at the cellular level by the end of 2024.
---
Ownership Overview
27.80% Insiders
10.95% Mutual Funds
4.85% Other Institutional Investors
51.43% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CBUS FAQ
What was Cibus’s price range in the past 12 months?
Cibus lowest stock price was $1.75 and its highest was $21.23 in the past 12 months.
What is Cibus’s market cap?
Cibus’s market cap is $63.25M.
When is Cibus’s upcoming earnings report date?
Cibus’s upcoming earnings report date is May 08, 2025 which is in 34 days.
How were Cibus’s earnings last quarter?
Cibus released its earnings results on Mar 20, 2025. The company reported -$0.87 earnings per share for the quarter, missing the consensus estimate of -$0.677 by -$0.193.
Is Cibus overvalued?
According to Wall Street analysts Cibus’s price is currently Undervalued.
Does Cibus pay dividends?
Cibus does not currently pay dividends.
What is Cibus’s EPS estimate?
Cibus’s EPS estimate is -0.51.
How many shares outstanding does Cibus have?
Cibus has 32,850,025 shares outstanding.
What happened to Cibus’s price movement after its last earnings report?
Cibus reported an EPS of -$0.87 in its last earnings report, missing expectations of -$0.677. Following the earnings report the stock price went down -6.393%.
Which hedge fund is a major shareholder of Cibus?
Currently, no hedge funds are holding shares in CBUS
---
Cibus Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$21.50 (1227.16% Upside)
$21.50 (1227.16% Upside)
Blogger Sentiment
Bullish
CBUS Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 20.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $24.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.5%
Last 30 Days <0.1%
Last 30 Days <0.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-90.61%
12-Months-Change
Fundamentals
Return on Equity
-130.38%
Trailing 12-Months
Asset Growth
-35.70%
Trailing 12-Months
Company Description
Cibus
Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.
---
CBUS Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant progress in strategic partnerships, regulatory advancements, and market expansion, particularly in gene editing and sustainable ingredients. However, the company faces challenges with limited cash reserves and the need for additional financing. The transition in leadership is noteworthy, but the overall narrative remains one of cautious optimism about future revenue opportunities.Read More>---
CBUS Stock 12 Month Forecast
Average Price Target
$21.50
▲(1227.16% Upside)
Technical Analysis
Codexis
―
FMC
―
Intellia Therapeutics
―
Bioceres Crop Solutions
―
Ginkgo Bioworks Holdings
―
Best Analysts Covering CBUS
1 Year
1 Year Success Rate
0/7 ratings generated profit
1 Year Average Return
-53.33%
reiterated a buy rating 15 days ago
Copying Austin Moeller's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -53.33% per trade.
---